Societal CDMO, Inc. (SCTL)
Company Description
Societal CDMO, Inc., a contract development and manufacturing organization, engages in the development, manufacturing, and packaging for various therapeutic dosage forms primarily in the small molecule therapeutic development in the United States and internationally.
It offers its products in the form of oral solid doses, sterile injectables, oral liquids, tablets, topicals, liquid/powder filled capsules, ophthalmic droppers, liposomes, and nano/microparticles, as well as in the areas of aseptic fill/finish, lyophilization, packaging, and logistics services.
The company was formerly known as Recro Pharma, Inc. and changed its name to Societal CDMO, Inc. in March 2022. Societal CDMO, Inc. was incorporated in 2007 and is based in Exton, Pennsylvania.
| Country | United States |
| Founded | 2007 |
| IPO Date | Mar 7, 2014 |
| Industry | Drug Manufacturers-Specialty & Generic |
| Sector | Health Care |
| Employees | 185 |
Contact Details
Address:
1 E. Uwchlan Avenue Exton, PA 19341 United States | |
| Phone | 770 534 8239 |
| Website | recropharma.com |
Stock Details
| Ticker Symbol | SCTL |
| Exchange | NASDAQ |
| Fiscal Year | January - December |
| Reporting Currency | US Dollars |
| CIK Code | 0001588972 |
| ISIN Number | US75629F1093 |
| SIC Code | 2834 |
Key Executives
| Name | Position |
|---|---|
| J. David Enloe Jr. | President, Chief Executive Officer and Director |
| Ryan D. Lake CPA | Chief Financial Officer |
| Marshall Rizzo M.B.A. | Senior Vice President of Operations |
| Richard Sidwell Ph.D. | Vice President and Chief Scientific Officer |
| Cristin Grove | Vice President of Sales |
| Erica Raether M.A. | Vice President of People, Culture and ESG |
| Randall J. Mack | Senior Vice President of Development |
| Eduardo Uribe | Head of Quality of San Diego |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Jul 5, 2022 | SC TO-I/A | Tender offer statement by Issuer |
| Jul 5, 2022 | 4 | Statement of changes in beneficial ownership of securities |
| Jun 30, 2022 | 8-K | Current report |
| Jun 27, 2022 | SC 13D | General statement of acquisition of beneficial ownership |
| Jun 17, 2022 | 4 | Statement of changes in beneficial ownership of securities |
| Jun 13, 2022 | SC TO-I/A | Tender offer statement by Issuer |
| Jun 8, 2022 | 8-K | Current report |
| Jun 2, 2022 | 4 | Statement of changes in beneficial ownership of securities |
| Jun 1, 2022 | SC TO-I | Tender offer statement by Issuer |
| May 20, 2022 | 4 | Statement of changes in beneficial ownership of securities |